Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 4/2006

01.04.2006 | Laboratory Investigation

Nerve growth factor modulates in vitro the expression and release of TGF-β1 by amniotic membrane

verfasst von: Marco Coassin, Alessandro Lambiase, Alessandra Micera, Paola Tirassa, Luigi Aloe, Stefano Bonini

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To determinate the basal production of NGF and TGF-β1 by amniotic membrane (AM) and to verify the presence of NGF receptors (trkANGFR and p75NTR) in AM. Thereafter, to evaluate in an in vitro model if increasing concentrations of NGF are able to stimulate AM to produce and release TGF-β1.

Methods

Immunohistochemistry, ELISA, in situ hybridization and PCR analysis for NGF, TGF-β1, trkANGFR and p75NTR were performed to study their presence in AM. Amniotic membranes were stimulated in vitro with increasing concentrations of NGF. After 24 h, the amount of TGF- β1 in the AM tissue and in the culture medium was investigate.

Results

AM expressed TGF-β1, NGF, trkANGFR and p75NTR mRNAs and proteins and released basal amounts of NGF and TGF-β1 in the medium. Stimulation of AM by addition of NGF induced a significant (P<0.05) increase of TGF-β1 mRNA/protein in AM tissue as well as a release of TGF-β1 protein into the culture medium, in a dose-dependent fashion.

Conclusions

This study demonstrates that amniotic membrane releases basal amounts of NGF and TGF-β1 and expresses NGF receptors . Moreover, the addition of NGF to the culture medium stimulates the amniotic membrane to significantly increase the production and release of TGF-β1.
Literatur
1.
Zurück zum Zitat Abrahamian A, Xi MS, Donnelly JJ, Rockey JH (1995) Effect of interferon-gamma on the expression of transforming growth factor-beta by human corneal fibroblasts: role in corneal immunoseclusion. J Interferon Cytokine Res 15:323–330PubMedCrossRef Abrahamian A, Xi MS, Donnelly JJ, Rockey JH (1995) Effect of interferon-gamma on the expression of transforming growth factor-beta by human corneal fibroblasts: role in corneal immunoseclusion. J Interferon Cytokine Res 15:323–330PubMedCrossRef
2.
Zurück zum Zitat Baum J (2002) Thygeson lecture. Amniotic membrane transplantation: why is it effective? Cornea 21:339–341PubMedCrossRef Baum J (2002) Thygeson lecture. Amniotic membrane transplantation: why is it effective? Cornea 21:339–341PubMedCrossRef
3.
Zurück zum Zitat Bocchini V, Angeletti PU (1969) The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc Natl Acad Sci U S A 64:787–794PubMedCrossRef Bocchini V, Angeletti PU (1969) The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc Natl Acad Sci U S A 64:787–794PubMedCrossRef
4.
Zurück zum Zitat Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L (2000) Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 107:1347–1351PubMedCrossRef Bonini S, Lambiase A, Rama P, Caprioglio G, Aloe L (2000) Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 107:1347–1351PubMedCrossRef
5.
Zurück zum Zitat Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286–1292PubMedCrossRef Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286–1292PubMedCrossRef
6.
Zurück zum Zitat Chikama T, Fukuda K, Morishige N, Nishida T (1998) Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I. Lancet 351:1783–1784PubMedCrossRef Chikama T, Fukuda K, Morishige N, Nishida T (1998) Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I. Lancet 351:1783–1784PubMedCrossRef
7.
Zurück zum Zitat Chin D, Boyle GM, Parsons PG, Coman WB (2004) What is transforming growth factor-beta (TGF-beta)? Br J Plast Surg 57:215–221PubMedCrossRef Chin D, Boyle GM, Parsons PG, Coman WB (2004) What is transforming growth factor-beta (TGF-beta)? Br J Plast Surg 57:215–221PubMedCrossRef
8.
Zurück zum Zitat Cosgaya JM, Aranda A (1995) Nerve growth factor regulates transforming growth factor-beta 1 gene expression by both transcriptional and posttranscriptional mechanisms in PC12 cells. J Neurochem 65:2484–2490PubMedCrossRef Cosgaya JM, Aranda A (1995) Nerve growth factor regulates transforming growth factor-beta 1 gene expression by both transcriptional and posttranscriptional mechanisms in PC12 cells. J Neurochem 65:2484–2490PubMedCrossRef
9.
Zurück zum Zitat Dua HS, Gomes JA, King AJ, Maharajan VS (2004) The amniotic membrane in ophthalmology. Surv Ophthalmol 49:51–77PubMedCrossRef Dua HS, Gomes JA, King AJ, Maharajan VS (2004) The amniotic membrane in ophthalmology. Surv Ophthalmol 49:51–77PubMedCrossRef
10.
Zurück zum Zitat Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S (2000) Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 19:113–129PubMedCrossRef Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S (2000) Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 19:113–129PubMedCrossRef
11.
Zurück zum Zitat Jester JV, Ho-Chang J (2003) Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res 77:581–592PubMedCrossRef Jester JV, Ho-Chang J (2003) Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res 77:581–592PubMedCrossRef
12.
Zurück zum Zitat Joyce NC, Zieske JD (1997) Transforming growth factor-beta receptor expression in human cornea. Invest Ophthalmol Vis Sci 38:1922–1928PubMed Joyce NC, Zieske JD (1997) Transforming growth factor-beta receptor expression in human cornea. Invest Ophthalmol Vis Sci 38:1922–1928PubMed
13.
Zurück zum Zitat King WJ, Comer RM, Hudde T, Larkin DF, George AJ (2000) Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation 70:1225–1233PubMedCrossRef King WJ, Comer RM, Hudde T, Larkin DF, George AJ (2000) Cytokine and chemokine expression kinetics after corneal transplantation. Transplantation 70:1225–1233PubMedCrossRef
14.
Zurück zum Zitat Klenkler B, Sheardown H (2004) Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp Eye Res 79:677–688PubMedCrossRef Klenkler B, Sheardown H (2004) Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. Exp Eye Res 79:677–688PubMedCrossRef
15.
Zurück zum Zitat Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S (2000) Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res 20:173–177PubMedCrossRef Koizumi NJ, Inatomi TJ, Sotozono CJ, Fullwood NJ, Quantock AJ, Kinoshita S (2000) Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res 20:173–177PubMedCrossRef
16.
Zurück zum Zitat Kruse FE, Tseng SCG (1993) Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium. Invest Ophthalmol Vis Sci 34:963–976 Kruse FE, Tseng SCG (1993) Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium. Invest Ophthalmol Vis Sci 34:963–976
17.
Zurück zum Zitat Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L (1998) Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 338:1174–1180PubMedCrossRef Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L (1998) Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 338:1174–1180PubMedCrossRef
18.
Zurück zum Zitat Lambiase A, Bonini S, Micera A, Rama P, Bonini S, Aloe L (1998) Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci 39:1272–1275PubMed Lambiase A, Bonini S, Micera A, Rama P, Bonini S, Aloe L (1998) Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci 39:1272–1275PubMed
19.
Zurück zum Zitat Lambiase A, Manni L, Bonini S, Rama P, Micera A, Aloe L (2000) Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci 41:1063–1069PubMed Lambiase A, Manni L, Bonini S, Rama P, Micera A, Aloe L (2000) Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci 41:1063–1069PubMed
20.
Zurück zum Zitat Lambiase A, Bonini S, Aloe L, Rama P, Bonini S (2000) Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol 118:1446–1449PubMed Lambiase A, Bonini S, Aloe L, Rama P, Bonini S (2000) Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol 118:1446–1449PubMed
21.
Zurück zum Zitat Lee SH, Tseng SC (1997) Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 123:303–312PubMed Lee SH, Tseng SC (1997) Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 123:303–312PubMed
22.
23.
Zurück zum Zitat Levi-Montalcini R, Aloe L, Alleva E (1990) A role for nerve growth factor in nervous, endocrine and immune system. Prog NeuroEndocrinImmunol 3:1–10 Levi-Montalcini R, Aloe L, Alleva E (1990) A role for nerve growth factor in nervous, endocrine and immune system. Prog NeuroEndocrinImmunol 3:1–10
24.
Zurück zum Zitat Micera A, Lambiase A, Aloe L, Bonini S, Levi-Schaffer F, Bonini S (2004) Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases. Cytokine Growth Factor Rev 15:411–417CrossRefPubMed Micera A, Lambiase A, Aloe L, Bonini S, Levi-Schaffer F, Bonini S (2004) Nerve growth factor involvement in the visual system: implications in allergic and neurodegenerative diseases. Cytokine Growth Factor Rev 15:411–417CrossRefPubMed
25.
Zurück zum Zitat Micera A, Puxeddu I, Aloe L, Levi-Schaffer F (2003) New insights on the involvement of nerve growth factor in allergic inflammation and fibrosis. Cytokine Growth Factor Rev 14:369–374CrossRefPubMed Micera A, Puxeddu I, Aloe L, Levi-Schaffer F (2003) New insights on the involvement of nerve growth factor in allergic inflammation and fibrosis. Cytokine Growth Factor Rev 14:369–374CrossRefPubMed
26.
Zurück zum Zitat Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, Maquart FX, Aloe L, Levi-Schaffer F (2001) Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A 98:6162–6167CrossRefPubMed Micera A, Vigneti E, Pickholtz D, Reich R, Pappo O, Bonini S, Maquart FX, Aloe L, Levi-Schaffer F (2001) Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A 98:6162–6167CrossRefPubMed
27.
Zurück zum Zitat Nakamura K (2003) Related Interaction between injured corneal epithelial cells and stromal cells. Cornea. 22:S35–S47CrossRefPubMed Nakamura K (2003) Related Interaction between injured corneal epithelial cells and stromal cells. Cornea. 22:S35–S47CrossRefPubMed
28.
Zurück zum Zitat Nishida K, Sotozono C, Adachi W, Yamamoto S, Yokoi N, Kinoshita S (1995) Transforming growth factor-beta 1, -beta 2 and -beta 3 mRNA expression in human cornea. Curr Eye Res 14:235-241PubMedCrossRef Nishida K, Sotozono C, Adachi W, Yamamoto S, Yokoi N, Kinoshita S (1995) Transforming growth factor-beta 1, -beta 2 and -beta 3 mRNA expression in human cornea. Curr Eye Res 14:235-241PubMedCrossRef
29.
Zurück zum Zitat Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36CrossRefPubMed Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30:e36CrossRefPubMed
30.
Zurück zum Zitat Saika S (2004) TGF-beta signal transduction in corneal wound healing as a therapeutic target. Cornea 23:S25–S30CrossRefPubMed Saika S (2004) TGF-beta signal transduction in corneal wound healing as a therapeutic target. Cornea 23:S25–S30CrossRefPubMed
31.
Zurück zum Zitat Saika S, Okada Y, Miyamoto T, Yamanaka O, Ohnishi Y, Ooshima A, Liu CY, Weng D, Kao WW (2004) Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest Ophthalmol Vis Sci 45:100–109CrossRefPubMed Saika S, Okada Y, Miyamoto T, Yamanaka O, Ohnishi Y, Ooshima A, Liu CY, Weng D, Kao WW (2004) Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest Ophthalmol Vis Sci 45:100–109CrossRefPubMed
32.
Zurück zum Zitat Sakamoto T, Ueno H, Sonoda K, Hisatomi T, Shimizu K, Ohashi H, Inomata H (2000) Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis. Gene Ther 7:1915–1924CrossRefPubMed Sakamoto T, Ueno H, Sonoda K, Hisatomi T, Shimizu K, Ohashi H, Inomata H (2000) Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis. Gene Ther 7:1915–1924CrossRefPubMed
33.
Zurück zum Zitat Sippel KC, Ma JJ, Foster CS (2001) Amniotic membrane surgery. Curr Opin Ophthalmol 12:269–281CrossRefPubMed Sippel KC, Ma JJ, Foster CS (2001) Amniotic membrane surgery. Curr Opin Ophthalmol 12:269–281CrossRefPubMed
34.
Zurück zum Zitat Touhami A, Grueterich M, Tseng SCG (2002) The role of NGF signaling in human limbal epithelium expanded by amniotic membrane culture. Invest Ophthalmol Vis Sci 43:987–994PubMed Touhami A, Grueterich M, Tseng SCG (2002) The role of NGF signaling in human limbal epithelium expanded by amniotic membrane culture. Invest Ophthalmol Vis Sci 43:987–994PubMed
35.
Zurück zum Zitat Tseng SCG, Espana EM, Kawakita T, Di Pascuale MA, Li W, He H, Liu T, Cho T, Gao Y, Yeh L, Liu C (2004) How does amniotic membrane work? Ocular Surf 2:177–187 Tseng SCG, Espana EM, Kawakita T, Di Pascuale MA, Li W, He H, Liu T, Cho T, Gao Y, Yeh L, Liu C (2004) How does amniotic membrane work? Ocular Surf 2:177–187
36.
Zurück zum Zitat Wahl SM, Swisher J, McCartney-Francis N, Chen W (2004) TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells. J Leukoc Biol 76:15–24CrossRefPubMed Wahl SM, Swisher J, McCartney-Francis N, Chen W (2004) TGF-beta: the perpetrator of immune suppression by regulatory T cells and suicidal T cells. J Leukoc Biol 76:15–24CrossRefPubMed
37.
Zurück zum Zitat You L, Kruse FE, Volcker HE (2000) Neurotrophic factors in the human cornea. Invest Ophthalmol Vis Sci 41:692–702PubMed You L, Kruse FE, Volcker HE (2000) Neurotrophic factors in the human cornea. Invest Ophthalmol Vis Sci 41:692–702PubMed
38.
Zurück zum Zitat Zieske JD, Hutcheon AE, Guo X, Chung EH, Joyce NC (2001) TGF-beta receptor types I and II are differentially expressed during corneal epithelial wound repair. Invest Ophthalmol Vis Sci 42:1465–1471PubMed Zieske JD, Hutcheon AE, Guo X, Chung EH, Joyce NC (2001) TGF-beta receptor types I and II are differentially expressed during corneal epithelial wound repair. Invest Ophthalmol Vis Sci 42:1465–1471PubMed
Metadaten
Titel
Nerve growth factor modulates in vitro the expression and release of TGF-β1 by amniotic membrane
verfasst von
Marco Coassin
Alessandro Lambiase
Alessandra Micera
Paola Tirassa
Luigi Aloe
Stefano Bonini
Publikationsdatum
01.04.2006
Verlag
Springer-Verlag
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 4/2006
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-005-0098-0

Weitere Artikel der Ausgabe 4/2006

Graefe's Archive for Clinical and Experimental Ophthalmology 4/2006 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.